Home › Obesità › Florida › Orlando
Studi clinici su Obesità a Orlando, FL
31 studi su Obesità cercano partecipanti presso sedi a Orlando e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
In reclutamentoFase 2
- Charter Research - Winter Park /ID# 281968, Orlando
- Florida Institute For Clinical Research /ID# 282739, Orlando
Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
In reclutamento
- Orlando Health, Inc., Orlando
A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
In reclutamentoFase 1Volontari sani benvenuti
- Kailera Clinical Site, Orlando
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
In reclutamentoFase 2
- Florida Institute For Clinical Research, LLC, Orlando
- K2 Medical Research - Maitland, Maitland · a 6 mi di distanza
- Omega Research Orlando, Altamonte Springs · a 9 mi di distanza
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
In reclutamentoFase 3
- Florida Institute for Clinical Research, LLC, Orlando
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
In reclutamentoFase 2
- Clinical Site Partners, LLC DBA Flourish Research, Winter Park · a 5 mi di distanza
- K2 Medical Research Maitland LLC, Main Office, Maitland · a 6 mi di distanza
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
In reclutamentoFase 2
- Clinical Neuroscience Solutions, Orlando
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
In reclutamentoFase 3
- Clinical Neuroscience Solution, Orlando
- Florida Institute for Clinical Research, LLC, Orlando
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
In reclutamentoFase 3
- Florida Inst For Clin Res LLC, Orlando
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
In reclutamentoFase 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
In reclutamentoFase 3
- Florida Hospital- Center for Pediatric Research, Orlando
- Nemours Children's Health, Orlando
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
In reclutamentoFase 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
In reclutamentoFase 3
- Clinical Neuroscience Solution, Orlando
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
In reclutamentoFase 3
- Clinical Site Partners, LLC dba Flourish Research, Winter Park · a 5 mi di distanza
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
In reclutamentoFase 3
- Research Site, Ocoee · a 10 mi di distanza
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
In reclutamentoFase 3
- West Orange Endocrinology, Ocoee · a 10 mi di distanza
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
In reclutamentoFase 3
- Conquest Research, Winter Park · a 5 mi di distanza
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
In reclutamentoFase 2
- Charter Research - Winter Park, Orlando
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
In reclutamentoFase 3
- AURORA-1 Clinical Site, Winter Park · a 5 mi di distanza
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
In reclutamentoFase 3
- AURORA-2 Clinical Site, Winter Park · a 5 mi di distanza
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
In reclutamentoFase 3
- AdventHealth Orlando, Orlando
- Orlando Health Heart Institute, Orlando
- Guardian Research Organization LLC, Winter Park · a 5 mi di distanza
- e altri 1
Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households
In reclutamento
- University of Central Florida, Orlando
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
In reclutamentoFase 3Volontari sani benvenuti
- ACCOMPLISH-2 Research Site, Ocoee · a 10 mi di distanza
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
In reclutamentoFase 2
- Charter Research - Winter Park, Orlando
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
In reclutamentoFase 3
- Kailera Clinical Site, Orlando
- Kailera Clinical Site, Orlando
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
In reclutamentoFase 3
- Clinical Neuroscience Solutions - Orlando, Orlando
- Combined Research Orlando Phase I IV, Orlando
- Florida Institute for Clinical Research, Orlando
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
In reclutamentoFase 3
- Florida Institute for Clinical Research, Orlando
- Conquest Research - Winter Park, Winter Park · a 5 mi di distanza
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
In reclutamentoFase 3
- Clinical Neuroscience Solutions, Orlando
- Florida Institute for Clinical Research, Orlando
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
In reclutamentoFase 3
- Cardiovascular Institute of Orlando, Orlando
- Guardian Research Org LLC, Winter Park · a 5 mi di distanza
- K2 Medical Research, Maitland · a 6 mi di distanza
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
In reclutamentoFase 3
- ACCOMPLISH-1 Research Site, Ocoee · a 10 mi di distanza
Assessments of Adipogenesis, Lipid Turnover and Cellular Composition in Adipose Tissue in Response to Endurance Exercise
In reclutamentoVolontari sani benvenuti
- AdventHealth Translational Research Institute, Orlando
Studi su Obesità in altre città
- Houston, TX43 studi
- Chicago, IL41 studi
- New York City, NY40 studi
- San Antonio, TX40 studi
- Washington, DC33 studi
- Dallas, TX30 studi
- Boston, MA28 studi
- Las Vegas, NV27 studi
- Miami, FL27 studi
- Baltimore, MD25 studi
- Jacksonville, FL25 studi
- St. Louis, MO25 studi
Altri studi a Orlando
- Cancro del polmone non a piccole cellule44 studi
- Cancro metastatico29 studi
- Sovrappeso27 studi
- Morbo di Alzheimer25 studi
- Diabete di tipo 224 studi
- Cancro (tutti i tipi)24 studi
- Cancro al seno23 studi
- Cancro ovarico22 studi
- Colite ulcerosa22 studi
- Cancro ai polmoni21 studi
- Cancro colorettale19 studi
- Disturbo depressivo maggiore19 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.